Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Imaging Diagnostic Systems names new distributor for Oman
Shihab Muscat United (SMU) will market and service the CT Laser Mammography (CTLM) system to the private and public sector of Oman. Deborah O’Brien, senior vice president of
Shihab Muscat United (SMU) will market and service the CT Laser Mammography (CTLM) system to the private and public sector of Oman. Deborah O’Brien, senior vice president of
MannKind, a biopharmaceutical company, has submitted a new drug application to the FDA requesting approval of Afresa inhalation powder and the Afresa inhaler for the treatment of adults
Under terms of the agreement, Merck, whose researchers discovered the candidate, has granted Medicines for Malaria Venture (MMV) an exclusive, royalty-free license to pursue development of the investigational
The funding will support a Phase I/IIa clinical study to test the safety and the efficacy of the company’s product, BKT140 as a therapeutic treatment for myeloma and
The small business technology transfer (STTR) award will be used to support a research collaboration between Numerate and the laboratory of Chaitan Khosla, the Wells Rauser and Harold
Cardinal Health has opened a new facility in Omaha, Nebraska that manufactures radiopharmaceuticals, giving local physicians new tools that aid in the early diagnosis and treatment of disease.
According to the agreement, Vicor’s PD2i cardiac analyzer will be used by University of Rochester personnel to identify which of the 651 congestive heart failure patients who participated
Foundation Capital led the round and was joined by Lanza techVentures, both existing investors. Guido Lanza, president and CEO of Numerate, said: “This investment will help support our
Spectrum Pharmaceuticals, a biopharmaceutical company, has announced the closing of the transaction whereby Spectrum acquired 100% control of RIT Oncology to commercialize Zevalin in the US. In connection
Healthpoint, an affiliate of DFB Pharmaceuticals, a specialty pharmaceutical company, has initiated a Phase II clinical trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is